{"id":"https://openalex.org/W2186698061","doi":null,"title":"QUEST for a cure for hepatitis C virus: the end is in sight","display_name":"QUEST for a cure for hepatitis C virus: the end is in sight","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2186698061","mag":"2186698061"},"language":"en","primary_location":{"id":"mag:2186698061","doi":null,"is_oa":false,"landing_page_url":"https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(14)60807-2.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082393980","display_name":"Mehau Kulyk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mehau Kulyk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5082393980"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.8629999756813049},{"id":"https://openalex.org/keywords/direct-acting-antivirals","display_name":"direct-acting antivirals","score":0.9020000100135803},{"id":"https://openalex.org/keywords/boceprevir","display_name":"boceprevir","score":0.9139999747276306},{"id":"https://openalex.org/keywords/telaprevir","display_name":"telaprevir","score":1.0},{"id":"https://openalex.org/keywords/pegylated-interferon-alpha","display_name":"pegylated interferon-alpha","score":0.9639999866485596},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.8930000066757202},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5370000004768372},{"id":"https://openalex.org/keywords/compensated-cirrhosis","display_name":"compensated cirrhosis","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.9302831292152405},{"id":"https://openalex.org/C2777159539","wikidata":"https://www.wikidata.org/wiki/Q410551","display_name":"Boceprevir","level":5,"score":0.9253507852554321},{"id":"https://openalex.org/C2778159067","wikidata":"https://www.wikidata.org/wiki/Q408557","display_name":"Telaprevir","level":5,"score":0.9063931703567505},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7404159903526306},{"id":"https://openalex.org/C2778986448","wikidata":"https://www.wikidata.org/wiki/Q7517689","display_name":"Simeprevir","level":5,"score":0.5943206548690796},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5003542900085449},{"id":"https://openalex.org/C2778390639","wikidata":"https://www.wikidata.org/wiki/Q2502747","display_name":"Sofosbuvir","level":5,"score":0.4987046718597412},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.47253870964050293},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.47200605273246765},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4659830927848816},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.4378584921360016},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42396312952041626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38106727600097656},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32203400135040283},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.23591578006744385}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2186698061","doi":null,"is_oa":false,"landing_page_url":"https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(14)60807-2.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1973675889","https://openalex.org/W1977300462","https://openalex.org/W1980154502","https://openalex.org/W1980771473","https://openalex.org/W1989522599","https://openalex.org/W2016703647","https://openalex.org/W2017412627","https://openalex.org/W2043193067","https://openalex.org/W2060895146","https://openalex.org/W2063285149","https://openalex.org/W2078251659","https://openalex.org/W2081897332","https://openalex.org/W2083084243","https://openalex.org/W2092646281","https://openalex.org/W2094972821","https://openalex.org/W2109413486","https://openalex.org/W2125065061","https://openalex.org/W2125963799","https://openalex.org/W2127189337","https://openalex.org/W2134867985","https://openalex.org/W2143244227","https://openalex.org/W2143559032","https://openalex.org/W2151554611","https://openalex.org/W2765938367"],"related_works":["https://openalex.org/W1970780167","https://openalex.org/W1590460185","https://openalex.org/W2324839862","https://openalex.org/W7098267732","https://openalex.org/W2007894395","https://openalex.org/W2080410185","https://openalex.org/W1978773541","https://openalex.org/W1965742280","https://openalex.org/W2087049318","https://openalex.org/W2401986631"],"abstract_inverted_index":{"However,":[0,153],"less":[1],"than":[2,176],"50%":[3],"of":[4,22,31,38,44,62,90,103,133,145,156],"people":[5],"infected":[6],"with":[7,19,83,112,147,164,170,186],"HCV":[8,46,92,105,148],"genotype":[9,14,93,149],"1,":[10],"the":[11,54,67,88,104,124,128,134,154],"most":[12],"common":[13],"worldwide,":[15],"could":[16],"be":[17],"cured":[18],"a":[20],"regimen":[21],"pegylated":[23],"interferon":[24],"(peginterferon)":[25],"alfa":[26,179],"and":[27,58,75,85,109,131],"ribavirin.":[28],"The":[29],"development":[30],"direct-acting":[32,71],"antiviral":[33,39,72],"drugs,":[34],"representing":[35],"new":[36],"classes":[37],"compounds,":[40],"has":[41],"revolutionised":[42],"treatment":[43,89],"chronic":[45,91],"infection.":[47,95,151],"These":[48,96],"agents":[49],"target":[50],"key":[51],"steps":[52],"in":[53,81,143,162,184],"viral":[55,63,141],"life":[56],"cycle":[57],"are":[59,99,110],"potent":[60],"inhibitors":[61,102,161],"replication.":[64],"In":[65],"2011,":[66],"fi":[68,158],"rst":[69],"two":[70,97],"drugs":[73,98],"boceprevir":[74],"telaprevir":[76],"were":[77],"approved":[78],"for":[79,87,118],"use":[80,155],"combination":[82,163],"peginterferon":[84,165,178],"ribavirin":[86,167],"1":[94,150],"specifi":[100],"c":[101],"NS3/4A":[106],"serine":[107],"protease":[108,160],"associated":[111,169],"improved":[113],"response":[114,130],"rates.":[115],"When":[116],"administered":[117],"24":[119],"weeks":[120],"or":[121],"48":[122],"weeks,":[123],"duration":[125],"depending":[126],"on":[127],"initial":[129],"severity":[132],"underlying":[135],"disease,":[136],"they":[137],"lead":[138],"to":[139],"sustained":[140],"clearance":[142],"66\u201375%":[144],"patients":[146,185],"5,6":[152],"these":[157],"rst-generation":[159],"plus":[166,180],"is":[168,177],"signifi":[171],"cantly":[172],"more":[173],"adverse":[174],"events":[175],"ribavirin,":[181],"including":[182],"death":[183],"compensated":[187],"cirrhosis.":[188],"7":[189]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}